M. Schlemmer

5.5k citations
64 papers · 3.2k indexed · 1 hit paper · h-index 26

M. Schlemmer

63 papers receiving 3.1k citations

Hit Papers

KIT mutations and dose selection for imatinib in patients...6542006202620122019200400600

Peers

M. Schlemmer
Comparison fields: 5 of 98
  • Gastroenterology 2.0k
  • Pulmonary and Respiratory Medicine 2.2k
  • Neurology 520
  • Surgery 1.2k
  • Oncology 557
Replace Pekka Tervahartiala with:
Pekka Tervahartiala Finland
Kirsten Sundby Hall Norway
A. Kevin Raymond United States
Sonja E. Steigen Norway
Inga‐Marie Schaefer United States
Beatrice Seddon United Kingdom
Thor Alvegård Sweden
Antonio López–Pousa Spain
Man H. Shiu United States
Kenneth Cardona United States
M. Schlemmer relative to Pekka Tervahartiala Finland Pekka Tervahartiala's profile →
Citations per field
00.5×4.2×
Pekka Tervahartiala · 1×
Citations per year

Countries citing papers authored by M. Schlemmer

Since Specialization
Citations

This map shows the geographic impact of M. Schlemmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schlemmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schlemmer more than expected).

Fields of papers citing papers by M. Schlemmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Schlemmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schlemmer. The network helps show where M. Schlemmer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M. Schlemmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Schlemmer Line = papers co-authored together M. Schlemmer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201819
2 201647
3 2015149
4 201297
5 201250
6 201125
7 20104
8 2009148
9 20097
10 200855
11 2008139
12 200721
13
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumoursbreakdown →
2006654
14 2005281
15 2004108
16 200414
17 200470
18 20036
19 20032
20 200221

About M. Schlemmer

M. Schlemmer is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Oncology, having authored 64 papers that have together received 3.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (30 papers), Gastrointestinal Tumor Research and Treatment (27 papers), Gastric Cancer Management and Outcomes (18 papers), Gastrointestinal disorders and treatments (10 papers), Vascular Tumors and Angiosarcomas (5 papers), Cardiac tumors and thrombi (4 papers), Renal and related cancers (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Gastroenterology (2.0k citations), Pulmonary and Respiratory Medicine (2.2k citations) and Neurology (520 citations). M. Schlemmer has collaborated with scholars based in Germany, France and Italy. Frequent co-authors include Jean‐Yves Blay, Paolo G. Casali, Peter Reichardt, Jaap Verweij, Ian Judson, M. van Glabbeke, Peter Hohenberger, John Zalcberg, Raf Sciot and Allan T. van Oosterom. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, International Journal of Hyperthermia and RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026